MAIDA ANTHONY E III 4
4 · INNOVATE BIOPHARMACEUTICALS, INC. · Filed Jun 4, 2019
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-31+25,000→ 25,000 totalExercise: $1.28Exp: 2029-05-31→ Common stock (25,000 underlying)
Footnotes (1)
- [F1]Grant to the reporting person of stock options under the Innovate Biopharmaceuticals, Inc. 2012 Omnibus Incentive Plan. These stock options vest in 36 equal monthly installments.